Andere Sprachen genedrive plc

Aktien

Verzögert London S.E. Andere Börsenplätze 17:35:07 03.05.2024			% 5 Tage	% 1. Jan.
4,375 ^GBX	-0,57 %		-18,60 %	-46,15 %

24.04.	Genedrive schließt Vereinbarung über klinische Studien in den USA für MT-RNR1 US-Zulassung ab	AN
03.04.	FTSE 100 dank US-Wirtschaftsdaten im Plus	AN

Genedrive enters clinical trial deal in US for MT-RNR1 US approval	24.04.
FTSE 100 up thanks to US economic data	03.04.
Genedrive shares surge as UK's NICE backs test for ischaemic stroke	03.04.
AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal	03.04.
Genedrive's Test Receives Draft Recommendation from UK's NICE	03.04.
EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate	28.03.
Genedrive plc Reports Earnings Results for the Half Year Ended December 31, 2023	28.03.
Genedrive down as plans equity raise despite GBP800,000 tax credit	15.03.
Coro seals sale terms, Powerhouse makes good progress	19.02.
Genedrive Seeks Funding for Testing Kit Amid Funding Call Launch of UK-backed Program	19.02.
MoneySupermarket credits Insurance for growth in 2023	19.02.
Genedrive draws down GBP600,000 on prepayment facility	02.01.
Genedrive Secures Financing Under Equity Prepayment Facility	02.01.
AIM WINNERS & LOSERS: Genedrive shares jump on orders	20.12.
Genedrive shares surge as six countries receive first orders	20.12.
Genedrive Jumps on Receipt of Initial Orders for MT-RNR1 Products	20.12.
Genedrive plc Announces Initial Overseas Orders of Mt-RNR1 Id Kit	20.12.
600 Group disposal and funding talks continue	04.12.
Genedrive plc Announces the Genedrive MT-RNR1 Id Kit Is Now in Routine Use in the Trevor Mann Baby Unit	04.12.
Genedrive shares fall as annual loss widens but focused on investing	30.11.

Keine Ergebnisse zu dieser Suche